VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 361 filers reported holding VANECK VECTORS ETF TR in Q2 2016. The put-call ratio across all filers is 1.14 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $546,000 | +43.7% | 20,441 | +37.5% | 0.43% | +46.9% |
| Q2 2019 | $380,000 | +18.0% | 14,861 | +3.6% | 0.29% | +14.6% |
| Q1 2019 | $322,000 | +33.6% | 14,350 | +25.7% | 0.25% | +39.0% |
| Q4 2018 | $241,000 | -37.1% | 11,416 | -44.8% | 0.18% | -26.9% |
| Q3 2018 | $383,000 | -24.3% | 20,665 | -8.9% | 0.25% | -32.7% |
| Q2 2018 | $506,000 | -18.3% | 22,683 | -19.4% | 0.37% | +56.8% |
| Q1 2018 | $619,000 | +133.6% | 28,152 | +147.3% | 0.24% | +187.8% |
| Q4 2017 | $265,000 | +76.7% | 11,386 | +74.4% | 0.08% | +67.3% |
| Q3 2017 | $150,000 | +614.3% | 6,527 | +581.3% | 0.05% | +600.0% |
| Q2 2017 | $21,000 | -4.5% | 958 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $22,000 | +10.0% | 958 | 0.0% | 0.01% | +28.6% |
| Q4 2016 | $20,000 | -20.0% | 958 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $25,000 | -62.7% | 958 | -60.1% | 0.01% | -71.0% |
| Q2 2016 | $67,000 | – | 2,404 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |